You are here

familial amyloid polyneuropathy

Alnylam’s rare disease drug shines in trial, paving way for a brand-new class of medicines

Stat

Wed, 09/20/17 - 09:27 am

familial amyloid polyneuropathy

GSK Hands Nerve Drug Back to Ionis as RNA Battle Heats Up

Xconomy

Fri, 08/11/17 - 11:37 am

familial amyloid polyneuropathy

Alnylam Drug Scores Against Rare Nerve Disease

Investors.com

Mon, 10/13/14 - 04:02 pm

familial amyloid polyneuropathy

Isis Pharmaceuticals receives $1M milestone payment from GlaxoSmithKline

The Fly on the Wall

Tue, 06/24/14 - 10:22 am

Isis Pharmaceuticals

familial amyloid polyneuropathy

Pfizer says FDA wants a new study of Vyndaqel

Yahoo/AP

Mon, 06/18/12 - 09:21 pm

familial amyloid polyneuropathy

The Meaningless Drug Approval That Could Cost the Industry Billions

Motley Fool

Mon, 05/28/12 - 11:16 am

familial amyloid polyneuropathy

FDA Panel Sends Mixed Message About Pfizer Drug

Pharmalot

Fri, 05/25/12 - 11:19 am

familial amyloid polyneuropathy

FDA staff shoots down Pfizer rare disease drug

Yahoo/Reuters

Tue, 05/22/12 - 11:19 am

familial amyloid polyneuropathy